10th February, 2012
Local research has shown that erectile dysfunction, one of the major causes of infertility is on the rise in Nigeria. This was made known by GreenLife Pharmaceutical Ltd. in Lagos at the public presentation of MANIX, a herbal medicine for tackling the health condition. According to the statement read by Gbenga Afolabi, a senior official on behalf of the company, “in a recent study in Nigeria, 57 per cent of men over 35 years have reported incidences of erectile dysfunction. Still most men feel reluctant to or embarrassed to discuss this problem with their doctors or seek treatment.”
Erectile dysfunction is a health condition that develops over time and destroys essential tissues. The result is inability to sustain erection, enjoy sex and in extreme cases can lead to the absence of a passion for sex in couples. It also results in low sperm volume and poor quality of sperm produced during ejaculation.
To ameliorate this nagging problem, he said the company is partnering with Wockhardt, an Indian-based pharmaceutical manufacturing firm to make MANIX available in the Nigerian market.
Also Speaking at the event, Hamashu Katira, Wockhardt Production Development Manager, noted that “infertility has become a global problem and in this part of the world, we are even deprived of finding out what the causes are.”
He explained that extensive scientific research on the product has been done in India and other parts of the world and have been found to be efficacious and in accordance with acceptable practices
Katira explained that MANIX as a natural substance stimulates the body to generate erection itself. The new drug, he added, is enhances the generation, development and maturation of sperm by increasing its volume, motility and count by about four times the normal output. Unlike the popular aphrodisiacs, MANIX is said to cleanse the body through a process regeneration without any untoward effects.
Chairman Greenlife Pharmaceutical, Dr. Obiora Chukwuka, said as one of the biggest drug manufacturers in India, his company decided to collaborate with them to market the product because of Wockhardt’s pedigree and the health viability of its product.
Kehinde Adegoke a laboratory scientist with the University of Lagos Teaching Hospital, LASUTH, attested that laboratory tests he conducted with an Urologist at LASUTH affirmed the potency of the drug.
The company said necessary steps have been taken to protect the drug from counterfeiters and peddlers.
Apart from the NAFDAC registration particulars and other special features, it warned potential counterfeiters to desist because the firm will deploy modern technological ways to stop the sale of fake brands in the market.
—Bankong-Obi